![[personal profile]](https://www.dreamwidth.org/img/silk/identity/user.png){kind=small}
ITEM [via BoingBoing]: The FDA assigns KV Pharmaceuticals an exclusive right to create Makena, a progesterone hormone injection used to prevent preterm labor.
Result: the cost of the drug goes up from $10 a shot to $1,500 a shot.
And this is the best part:
To be fair, KV Pharma has said it will subsidize Makena for households (both insured and uninsured) that make under $100K a year.
However, that also means a lengthy approval process that could delay treatment, which could result in preterm birth.
DISCLAIMER [paraphrasing Bill Hicks]: There is no connection between this and the high cost of healthcare. And you’d be a fool and a Socialist to make one.
All major credit cards accepted,
This is dF
Result: the cost of the drug goes up from $10 a shot to $1,500 a shot.
And this is the best part:
Many doctors are particularly frustrated with the price hike because to date, KV Pharmaceuticals has not had to bear the cost of the clinical trials used to get the drug approved, but they have announced plans to conduct further trials in the future.
"All the upfront development of the drug was done by the National Institute of Health. You and I paid for that with our tax dollars, it's not like this pharmaceutical company is trying to recoup its investments in research and development, as is usually the reason for the price of new drugs," says Dr. Kevin Ault, associate professor of gynecology and obstetrics at Emory University School of Medicine.
"All the upfront development of the drug was done by the National Institute of Health. You and I paid for that with our tax dollars, it's not like this pharmaceutical company is trying to recoup its investments in research and development, as is usually the reason for the price of new drugs," says Dr. Kevin Ault, associate professor of gynecology and obstetrics at Emory University School of Medicine.
To be fair, KV Pharma has said it will subsidize Makena for households (both insured and uninsured) that make under $100K a year.
However, that also means a lengthy approval process that could delay treatment, which could result in preterm birth.
DISCLAIMER [paraphrasing Bill Hicks]: There is no connection between this and the high cost of healthcare. And you’d be a fool and a Socialist to make one.
All major credit cards accepted,
This is dF
